The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab

PURPOSE: This prospective study was to investigate the value of [(11)C]-acetate PET and [(18)F]-FDG PET in the evaluation of hepatocellular carcinoma (HCC) before and after treatment with transarterial chemoembolization (TACE) and vascular endothelial growth factor (VEGF) antibody (bevacizumab). MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Nucl Med Mol Imaging
Autors principals: Li, Shuren, Peck-Radosavljevic, Markus, Ubl, Philipp, Wadsak, Wolfgang, Mitterhauser, Markus, Rainer, Eva, Pinter, Matthias, Wang, Hao, Nanoff, Christian, Kaczirek, Klaus, Haug, Alexander, Hacker, Marcus
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5537334/
https://ncbi.nlm.nih.gov/pubmed/28555333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3724-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars